Video: AI-Enabled Technology

Despite a boom in tech funding and monumental advancements in AI/ML and in silico models, tech advancements have not yet translated into marked efficiency improvements at clinical research sites. Most clinical trials still fail to meet enrollment timelines, with most delays occurring at the site level. To gain efficiency, technology must enhance clinical trials at their most critical point — closest to patients, at the sites.

With a fully owned technology hub in Hyderabad, India, Velocity is building VISION, the first comprehensive technology platform built by sites, for sites. Now and in the future, VISION is how Velocity will deliver accurate data, broader patient access, and operational excellence with unparalleled efficiency.

Learn more about VISION at

Posted in , ,

Quality. Continuity. Velocity.